Bispecific monoclonal antibodies for targeted immunotherapy of solid tumors: Recent advances and clinical trials

Seyed Samad Hosseini; Saeed Khalili; Behzad Baradaran; Negar Bidar; Mohammad‐Ali Shahbazi; Jafar Mosafer; Mahmoud Hashemzaei; Ahad Mokhtarzadeh; Michael R Hamblin

doi:10.1016/j.ijbiomac.2020.11.058

Related publications

Article2021

Recent Advances of AIEgens for Targeted Imaging of Subcellular Organelles

Nan Song, Peihong Xiao, Ke Ma, Miaomiao Kang, Wei Zhu, Jiachang Huang, Dong Wang, Ben Zhong Tang

Article2018

Trial Watch: Oncolytic viro-immunotherapy of hematologic and solid tumors

Jonathan Pol, Sarah Lévesque, Samuel T. Workenhe, Shashi Gujar, Fabrice Le Bœuf, Derek R. Clements, Jean‐Eudes Fahrner, Laetitia Fend, John C. Bell, Karen Mossman, Jitka Fučíková, Radek Špíšek, Laurence Zitvogel, Guido Guido Kroemer, Lorenzo Galluzzi

Article2022

Recent advances in the biosynthesis, structure–activity relationships, formulations, pharmacology, and clinical trials of fisetin

Ruting Zhong, Mohamed A. Farag, Meiwan Chen, Chengwei He, Jianbo Xiao

Article2019

Recent advances in porphyrin-based nanocomposites for effective targeted imaging and therapy

Navid Rabiee, Mohammad Tavakkoli Yaraki, Soha Mokhtari Garakani, Shima Mokhtari Garakani, Sepideh Ahmadi, Aseman Lajevardi, Mojtaba Bagherzadeh, Mohammad Rabiee, Lobat Tayebi, Mohammadreza Tahriri, Michael R Hamblin

Article2004

Monoclonal gammopathy of undetermined significance (MGUS) in patients with solid tumors: effects of chemotherapy on the monoclonal protein

Αchilles Anagnostopoulos, Eleni Galani, Dimitra Gika, D Sotou, Aikaterini Evangelopoulou, Meletios A Dimopoulos